Global Suraputide Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

According to our (Global Info Research) latest study, the global Suraputide market size was valued at US$ 18.67 million in 2025 and is forecast to a readjusted size of US$ 540 million by 2032 with a CAGR of 16.8% during review period.
Suraputide is an innovative long‑acting GLP‑1 receptor agonist independently developed in China. By activating the GLP‑1 receptor, it promotes insulin secretion and inhibits glucagon release in a glucose‑dependent manner, thereby effectively lowering blood glucose. It also exerts effects of delaying gastric emptying, suppressing appetite, reducing body weight, and providing potential cardiorenal protection. The drug achieves long‑acting activity through Fc fusion protein technology and is administered by subcutaneous injection once weekly. It is mainly indicated for glycemic control in adults with type 2 diabetes mellitus. As the first domestically invented long‑acting GLP‑1 analogue approved in China, it features favorable safety, convenient administration and high compliance, and offers important clinical value for potential expansion into indications such as obesity and metabolic syndrome.In 2025, global Suraputide production reached approximately 300,000 vials.
As the first domestically developed long‑acting GLP‑1 receptor agonist in China, suraputide operates in a rapidly expanding and highly competitive market for metabolic disease drugs. With the convenience of once‑weekly administration, favorable safety profile, and locally tailored pricing advantages, the product has quickly entered the field of type 2 diabetes treatment since its launch. Its inclusion in medical insurance has further boosted both market coverage and patient accessibility. Although the current market is dominated by international pharmaceutical giants, accompanied by intensified competition among similar products and pressure on pricing, suraputide has established distinctive competitiveness in the two core sectors of diabetes and weight management by relying on its differentiated Fc fusion protein technology, as well as local R&D and commercialization strengths. In the long run, with the gradual expansion of indications to include obesity and metabolic syndrome, the advancement of overseas market deployment, and the rising penetration rate and consumption upgrade of GLP‑1 drugs in China, the product is expected to continuously expand its market share in the trillion‑level market and become an important benchmark for domestic innovative drugs in the field of metabolic diseases.
This report is a detailed and comprehensive analysis for global Suraputide market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Suraputide market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Suraputide market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Suraputide market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Suraputide market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Suraputide
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Suraputide market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Guangzhou InnoGen Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Suraputide market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
1 mg (0.5 mL) / pen
3 mg (0.5 mL) / pen
Market segment by Combination Therapy
Combination of Supaglutide and Metformin
Combination of Supaglutide and DPP-4 inhibitors
Market segment by Sales Channel
Hospital
Retail
Online
Market segment by Application
Type 2 Diabetes Mellitus
Obesity
Metabolic Syndrome
Others
Major players covered
Guangzhou InnoGen Pharmaceuticals
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Suraputide product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Suraputide, with price, sales quantity, revenue, and global market share of Suraputide from 2021 to 2026.
Chapter 3, the Suraputide competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Suraputide breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Suraputide market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Suraputide.
Chapter 14 and 15, to describe Suraputide sales channel, distributors, customers, research findings and conclusion.